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essential if drug misuse treatment is to be brought into
the mainstream. The guidelines represent a consensus
framework for good clinical practice,6 and clinicians
can expect to be judged against this reference point. If
we deviate from the guidelines we should defend such
deviation because they provide protection for the pub›
lic against practice which is deficient.
Jenny Keen Primary care specialist in drug dependence
Institute of General Practice and Primary Care, University of Sheffield,
Sheffield S5 7AU (j.keen@shef.ac.uk)
1 Department of Health. Drug misuse and dependence: guidelines on clinical
management. London: Stationery Office, 1999.
2 Department of Health. Task force to review services for drug misusers: report
of an independent review of drug treatment services in England. London:
Department of Health, 1996.
3 Farrell M, Hall W. The Swiss heroin trials: testing alternative approaches.
BMJ 1998,316:639.
4 Farrell M, Ward J, Mattick R, Hall W, Stimson G, des Jarlais D, et al. Metha›
done maintenance treatment in opiate dependence: a review. BMJ
1994:309:997›1001.
5 Ward J, Hall W, Mattick R. Role of maintenance treatment in opioid
dependence. Lancet 1999;353:221›6.
6 Tackling drugs to build a better Britain: the government’s ten›year strategy for
tackling drugs misuse. London: Stationery Office, 1998.
Minimising the impact of visual impairment
Low vision aids are a simple way of alleviating impairment
Visual impairment is responsible for much indi›vidual suffering and economic hardship. Mag›nifying devices and other types of low vision
aid can significantly reduce the degree of handicap
associated with impaired vision. Two thirds of the
people who would benefit from a low vision aid (about
600 000 people in the United Kingdom), however, do
not possess one.1 What are the reasons for this disturb›
ing situation?
Currently about 316 000 people are registered as
blind or partially sighted. However, the registers
underestimate the number of people with low vision by
a factor of three,2 so almost 1 000 000 people in the
United Kingdom have untreatable low vision. Commu›
nity based surveys support this estimate and have
shown that around 20% of those aged 75 and over
have visual acuity less than 6/12.3 With the advent of
annual screening for patients over 75 and the high
prevalence of visual impairment, general practitioners
are becoming increasingly familiar with low vision and
its associated problems such as depression and falls.4 5
Demographic trends indicate that the situation is
likely to get worse because the causes of low vision are
predominantly age related. Unfortunately, medical
intervention is unlikely to offer much help. No treatment
currently exists for age related maculopathy, the primary
cause of visual impairment in the United Kingdom. Fur›
thermore, although continuing advances in the manage›
ment of conditions such as glaucoma and diabetes are
likely to reduce the degree of visual impairment associ›
ated with these conditions, the overall number of people
with impaired sight may not diminish because the ben›
efits of improved management are likely to be offset by
the general trend toward increased life expectancy.
In the absence of a cure for blindness, rehabilita›
tion is of paramount importance. The most effective
way to reduce the degree of handicap associated with
visual impairment is by providing low vision aids as
part of a comprehensive low vision service.1 When dis›
pensed appropriately these simple magnifying devices
enhance residual vision and often permit people with
impaired sight to perform daily tasks such as reading.
Regrettably, evidence based on observational studies
and expert opinion collated by the Partially Sighted
Society suggests that many people are not benefiting
from this simple form of management.1 The greatest
consequence of this failure is that many old people
require residential care because they can no longer live
alone.1 So why are low vision aids underused?
One reason might be that the benefits to be gained
from the use of low vision aids are not widely recognised
in the community. Yet the ability of these devices to alle›
viate the problems associated with visual impairment is
well established,1 6›8 and has been highlighed at Cardiff
University’s low vision clinic, which provides low vision
services for the people of south Wales. Data collected
over six months from 168 new referrals showed that,
although only about 20% of those referred could read
normal print when they first came to the clinic, this fig›
ure rose to almost 90% after provision of a suitable low
vision aid and some training (unpublished data). Rarely
can medical intervention be so effective. The improve›
ment in reading performance addresses the primary
complaint of people with age related maculopathy, and
it is perhaps for this reason that more than 80% of peo›
ple report a benefit from attending low vision clinics.6
Other reasons why people with impaired vision do not
benefit from a low vision assessment include the fact that
some may fail to recognise their degree of visual impair›
ment or fear treatment, the stigma of blindness, and dif›
ferences in ophthalmological referral criteria.
Nevertheless, low vision aids provide a simple and
effective means of alleviating the problems associated
with visual impairment. Greater provision of these
inexpensive devices would greatly reduce both the
social and economic impact of low vision.
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